» Articles » PMID: 32905889

Role of Inhaled Corticosteroids in Reducing Exacerbations in Bronchiectasis Patients with Blood Eosinophilia Pooled Post-hoc Analysis of 2 Randomized Clinical Trials

Overview
Journal Respir Med
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2020 Sep 9
PMID 32905889
Citations 13
Authors
Affiliations
Soon will be listed here.
Citing Articles

Bronchiectasis.

Raboso B, Pou C, Abril R, Erro M, Sanchez C, Manzano C Open Respir Arch. 2024; 6(3):100339.

PMID: 39026515 PMC: 11255363. DOI: 10.1016/j.opresp.2024.100339.


Bronchiectasis management in adults: state of the art and future directions.

Choi H, McShane P, Aliberti S, Chalmers J Eur Respir J. 2024; 63(6).

PMID: 38782469 PMC: 11211698. DOI: 10.1183/13993003.00518-2024.


Endotypes of Paediatric Cough-Do They Exist and Finding New Techniques to Improve Clinical Outcomes.

OFarrell H, Kok H, Goel S, Chang A, Yerkovich S J Clin Med. 2024; 13(3).

PMID: 38337450 PMC: 10856076. DOI: 10.3390/jcm13030756.


Simultaneous evaluation of the fractional exhaled nitric oxide and blood eosinophil count of T2-high endotype in patients with non-cystic fibrosis bronchiectasis.

Chen F, Zeng Z, Huang X, Liu Y Chron Respir Dis. 2023; 20:14799731231210559.

PMID: 37889184 PMC: 10612456. DOI: 10.1177/14799731231210559.


Blood eosinophil percentage as a predictor of response to inhaled corticosteroid in bronchiectasis.

Kwok W, Tam T, Lam D, Ip M, Man Ho J Clin Respir J. 2023; 17(6):548-555.

PMID: 37186375 PMC: 10265148. DOI: 10.1111/crj.13624.